STI Stock Trade Intelligence
HMD

HERAMED LIMITED

Health Care · ASX:HMD
$0.0340
▼ -2.86%
Market cap
$39M
Turnover
$1,734
Last price
$0.0340
Day change
-2.86%
Announcements
8
Range, past year
Open 0.037 · Low 0.006 · Now 0.034 · High 0.055
Open HMD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

HMD momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
16/100
Wyckoff phase
Downtrend1d
Trend stage
Breakdown
1 Day
-2.9%
1 Week
-8.1%
1 Month
+3.0%
1 Year
-5.6%
RSI
41
Avg daily range
4.7%

HERAMED LIMITED scores 16 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.

On the Wyckoff cycle it sits in Downtrend, where it has been for 1 trading day. The weekly timeframe reads Downtrend, which agrees with the daily view.

Against the wider market it is currently matching and the institutional accumulation signal reads low.

Points to watch
  • 60d drawdown -34.7%
  • Thin liquidity
  • Risk rating: Very High
  • Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

HMD announcements

Recent price-sensitive releases.
  • 2026-10-30 Quarterly Activities & Cashflow Report Commitments Test Entity - Third Quarter Activity Report | Commitments Test Entity - Third Quarter Cashflow Report
  • 2026-09-16 Lee Health Approves Expansion of HeraMED Maternity Program Trading Halt Lifted | Progress Report
  • 2026-09-15 Trading Halt Trading Halt
  • 2026-08-28 Appendix 4D and Half Year Report Half Yearly Report | Half Year Audit Review | Half Year Directors' Statement | Half Year Accounts | Half Year Directors' Report
  • 2026-07-31 Quarterly Activities & Cashflow Report Commitments Test Entity - Second Quarter Activity Report | Commitments Test Entity - Second Quarter Cashflow Report
  • 2026-07-14 HeraMED successfully completes Phase 1 pilot with Lee Health
  • 2026-04-30 Quarterly Activities & Cashflow Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.